VNDA has been in the news 1000% more than usual
Dec 31, 2025, 3:32 PM
-5.01%
What does VNDA do
Vanda Pharmaceuticals, headquartered in Washington, D.C., develops therapies for unmet medical needs and has three commercial products, including HETLIOZ and Fanapt. The company also has multiple drugs in development.
VNDA has been in the news recently: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is experiencing increased market interest, with its shares trending on Wednesday. The company reported a 20% increase in profits for the last quarter compared to the previous year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.